Inato Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 79

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $14.9M

  • Investors
  • 16

Inato General Information

Description

Operator of a global clinical trial marketplace intended to unlock trial access to patients globally and make clinical research inclusive and efficient. The company connects global pharmaceutical companies with a broader range of community research sites while ensuring reliable performance through collaborative enrollment planning and ongoing support, and ensuring that sites are successfully delivering trials, enabling doctors to get a tool to discover untapped research sites efficiently to select the right opportunities for them.

Contact Information

Website
www.inato.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 176 avenue Charles de Gaulle
  • 92200 Neuilly-sur-Seine
  • France
Primary Industry
Business/Productivity Software
Other Industries
Drug Discovery
Other Healthcare Services
Enterprise Systems (Healthcare)
Corporate Office
  • 176 avenue Charles de Gaulle
  • 92200 Neuilly-sur-Seine
  • France

Inato Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Inato Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC 04-Dec-2024 $14.9M Completed Generating Revenue
5. Later Stage VC (Series A2) 15-Mar-2023 Completed Generating Revenue
4. Early Stage VC (Series A) 04-Feb-2020 Completed Generating Revenue
3. Early Stage VC Completed Startup
2. Seed Round 15-Nov-2017 $1.52M $1.52M Completed Startup
1. Accelerator/Incubator 01-Oct-2017 Completed Startup
To view Inato’s complete valuation and funding history, request access »

Inato Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
ABSA B
A3 Shares
A2 Shares
A1 Shares 490,400 $0.010591 $21.06 $21.06 1x $21.06 16.29%
Seed 309,100 $0.010591 $4.45 $4.45 1x $4.45 10.27%
To view Inato’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Inato Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a global clinical trial marketplace intended to unlock trial access to patients globally and make clinical r
Business/Productivity Software
Neuilly-sur-Seine, France
79 As of 2026

Campbell, CA
 

Hamburg, Germany
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Inato Competitors (5)

One of Inato’s 5 competitors is Saama Analytics, a Venture Capital-Backed company based in Campbell, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Saama Analytics Venture Capital-Backed Campbell, CA
Clariness Private Equity-Backed Hamburg, Germany
TriNetX Private Equity-Backed Cambridge, MA
SubjectWell Private Equity-Backed Austin, TX
Trialmed Private Equity-Backed Irvine, CA
You’re viewing 5 of 5 competitors. Get the full list »

Inato Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Inato Investors (16)

Investor Name Investor Type Holding Investor Since Participating Rounds
Elaia Partners Venture Capital Minority
Racine2 Impact Investing Minority
Cathay Capital PE/Buyout Minority
La Maison Partners Venture Capital Minority
Top Harvest Capital Venture Capital Minority
You’re viewing 5 of 16 investors. Get the full list »

Inato FAQs

  • When was Inato founded?

    Inato was founded in 2016.

  • Where is Inato headquartered?

    Inato is headquartered in Neuilly-sur-Seine, France.

  • What is the size of Inato?

    Inato has 79 total employees.

  • What industry is Inato in?

    Inato’s primary industry is Business/Productivity Software.

  • Is Inato a private or public company?

    Inato is a Private company.

  • What is the current valuation of Inato?

    The current valuation of Inato is .

  • What is Inato’s current revenue?

    The current revenue for Inato is .

  • How much funding has Inato raised over time?

    Inato has raised $53.1M.

  • Who are Inato’s investors?

    Elaia Partners, Racine2, Cathay Capital, La Maison Partners, and Top Harvest Capital are 5 of 16 investors who have invested in Inato.

  • Who are Inato’s competitors?

    Saama Analytics, Clariness, TriNetX, SubjectWell, and Trialmed are competitors of Inato.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process